C. Laurent, N. Diakhate, N. Gueye, M. Toure, P. Sow et al., The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study, AIDS, vol.16, issue.10, pp.1363-1370, 2002.
DOI : 10.1097/00002030-200207050-00008

L. Ivers, D. Kendrick, and K. Doucette, Efficacy of Antiretroviral Therapy Programs in Resource???Poor Settings: A Meta???analysis of the Published Literature, Clinical Infectious Diseases, vol.41, issue.2, pp.217-224, 2005.
DOI : 10.1086/431199

A. Mosam, E. Cassol, T. Page, U. Bodasing, S. Cassol et al., Generic antiretroviral efficacy in AIDS-associated Kaposi??s sarcoma in sub-Saharan Africa, AIDS, vol.19, issue.4, pp.441-443, 2005.
DOI : 10.1097/01.aids.0000161775.36652.85

E. Mills, J. Nachega, D. Bangsberg, S. Singh, B. Rachlis et al., Adherence to HAART: A Systematic Review of Developed and Developing Nation Patient-Reported Barriers and Facilitators, PLoS Medicine, vol.24, issue.11, p.438, 2006.
DOI : 10.1371/journal.pmed.0030438.t007

J. Simoni, C. Pearson, D. Pantalone, G. Marks, and N. Crepaz, Efficacy of Interventions in Improving Highly Active Antiretroviral Therapy Adherence and HIV-1 RNA Viral Load, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.43, issue.Supplement 1, pp.23-35, 2006.
DOI : 10.1097/01.qai.0000248342.05438.52

C. Gill, D. Hamer, J. Simon, D. Thea, and L. Sabin, No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa, AIDS, vol.19, issue.12, pp.1243-1249, 2005.
DOI : 10.1097/01.aids.0000180094.04652.3b

A. Ammassari, R. Murri, P. Pezzotti, M. Trotta, L. Ravasio et al., Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.28, issue.5, pp.445-449, 2001.
DOI : 10.1097/00042560-200112150-00006

A. Bouhnik, M. Chesney, P. Carrieri, H. Gallais, J. Moreau et al., Nonadherence Among HIV-Infected Injecting Drug Users: The Impact of Social Instability, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.31, issue.3, pp.31-149, 2002.
DOI : 10.1097/00126334-200212153-00013

M. Carrieri, M. Chesney, B. Spire, A. Loundou, A. Sobel et al., Failure to maintain adherence to haart in a cohort of French HIV-positive injecting drug users, International Journal of Behavioral Medicine, vol.35, issue.2, pp.1-14, 2003.
DOI : 10.1207/S15327558IJBM1001_01

M. Carrieri, C. Leport, C. Protopopescu, J. Cassuto, E. Bouvet et al., Factors Associated With Nonadherence to Highly Active Antiretroviral Therapy, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.41, issue.4, pp.477-485, 2006.
DOI : 10.1097/01.qai.0000186364.27587.0e

S. Duran, B. Spire, F. Raffi, V. Walter, D. Bouhour et al., Self-Reported Symptoms After Initiation of a Protease Inhibitor in HIV-Infected Patients and Their Impact on Adherence to HAART, HIV Clinical Trials, vol.4, issue.9, pp.38-45, 2001.
DOI : 10.1097/00002030-199909100-00022

G. Alvarez-valdes, M. Gonzalez-lahoz, and J. , Psychological variables and adherence to antiretroviral treatment, An Med Interna, vol.17, pp.38-41, 2000.

P. Carrieri, V. Cailleton, L. Moing, V. Spire, B. Dellamonica et al., The Dynamic of Adherence to Highly Active Antiretroviral Therapy: Results From the French National APROCO Cohort, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.28, issue.3, pp.232-239, 2001.
DOI : 10.1097/00042560-200111010-00005

S. Sungkanuparph, W. Manosuthi, S. Kiertiburanakul, B. Piyavong, N. Chumpathat et al., Options for a Second-Line Antiretroviral Regimen for HIV Type 1-Infected Patients Whose Initial Regimen of a Fixed-Dose Combination of Stavudine, Lamivudine, and Nevirapine Fails, Clinical Infectious Diseases, vol.44, issue.3, pp.447-452, 2007.
DOI : 10.1086/510745

L. Ferradini, D. Laureillard, N. Prak, C. Ngeth, M. Fernandez et al., Positive Outcomes of HAART at 24 Months in HIV infected Patients in Cambodia AIDS

C. Tourette-turgis, Therapeutic care centered on compliance, Soins, pp.42-45, 2004.

C. Pradier, L. Bentz, B. Spire, C. Tourette-turgis, M. Morin et al., Efficacy of an Educational and Counseling Intervention on Adherence to Highly Active Antiretroviral Therapy: French Prospective Controlled Study, HIV Clin Trials, vol.4, pp.121-131, 2003.

M. Chesney, J. Ickovics, D. Chambers, A. Gifford, J. Neidig et al., Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG) AIDS Care, pp.255-266, 2000.

S. Duran, M. Saves, B. Spire, V. Cailleton, A. Sobel et al., Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy, AIDS, vol.15, issue.18, pp.2441-2444, 2001.
DOI : 10.1097/00002030-200112070-00012

A. Justice, W. Holmes, A. Gifford, L. Rabeneck, R. Zackin et al., Development and validation of a self-completed HIV symptom index, Journal of Clinical Epidemiology, vol.54, issue.12, pp.77-90, 2001.
DOI : 10.1016/S0895-4356(01)00449-8

B. Spire, S. Duran, M. Souville, C. Leport, F. Raffi et al., Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach, Social Science & Medicine, vol.54, issue.10, pp.1481-1496, 2002.
DOI : 10.1016/S0277-9536(01)00125-3

E. Vincent, A. Bouhnik, M. Carrieri, D. Rey, P. Dujardin et al., Impact of HAART-related side effects on unsafe sexual behaviours in HIV-infected injecting drug users, AIDS, vol.18, issue.9, pp.1321-1325, 2004.
DOI : 10.1097/00002030-200406180-00011

C. Pasquier, K. Sandres, G. Salama, J. Puel, and J. Izopet, Using RT-PCR and bDNA assays to measure non-clade B HIV-1 subtype RNA, Journal of Virological Methods, vol.81, issue.1-2, pp.123-129, 1999.
DOI : 10.1016/S0166-0934(99)00057-9

F. Rouet, D. Ekouevi, M. Chaix, M. Burgard, A. Inwoley et al., Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting, Journal of Clinical Microbiology, vol.43, issue.6, pp.2709-2717, 2005.
DOI : 10.1128/JCM.43.6.2709-2717.2005

G. King, L. Zeng, G. King, and L. Zeng, Logistic Regression in Rare Events Data Estimating Risk and Rate Levels, Ratios, and Differences in Case-Control Studies, Political analysis, vol.921, issue.26, pp.137-1631409, 2001.

M. Toms, G. King, L. Zeng, G. King, M. Toms et al., Rare Events Logistic Regressio Making the Most of Statistical Analyses, Journal of Statistical Software American Journal of Political Science, vol.844, issue.28, pp.347-361, 2000.

L. Ferradini, A. Jeannin, L. Pinoges, J. Izopet, D. Odhiambo et al., Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment, The Lancet, vol.367, issue.9519, pp.1335-1342, 2006.
DOI : 10.1016/S0140-6736(06)68580-2

E. Mills, J. Nachega, I. Buchan, J. Orbinski, A. Attaran et al., Adherence to Antiretroviral Therapy in Sub-Saharan Africa and North America, JAMA, vol.296, issue.6, pp.679-690, 2006.
DOI : 10.1001/jama.296.6.679

X. Gao, D. Nau, S. Rosenbluth, V. Scott, and C. Woodward, The relationship of disease severity, health beliefs and medication adherence among HIV patients, AIDS Care, vol.12, issue.4, pp.387-398, 2000.
DOI : 10.1080/09540120050123783

A. Fernandes, R. Sanches, J. Mill, D. Lucy, P. Palha et al., Lipodystrophy syndrome associated with antiretroviral therapy in HIV patients: considerations for psychosocial aspects, Revista Latino-Americana de Enfermagem, vol.15, issue.5, pp.1041-1045, 2007.
DOI : 10.1590/S0104-11692007000500024

S. Cohn, M. Berk, S. Berry, N. Duan, M. Frankel et al., The Care of HIV-Infected Adults in Rural Areas of the United States, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.28, issue.4, pp.385-392, 2001.
DOI : 10.1097/00126334-200112010-00013

S. Reif, C. Golin, and S. Smith, Barriers to accessing HIV/AIDS care in North Carolina: Rural and urban differences, AIDS Care, vol.133, issue.5, pp.558-565, 2005.
DOI : 10.1016/S0277-9536(01)00125-3

L. Rintamaki, T. Davis, S. Skripkauskas, C. Bennett, and M. Wolf, Social Stigma Concerns and HIV Medication Adherence, AIDS Patient Care and STDs, vol.20, issue.5, pp.359-368, 2006.
DOI : 10.1089/apc.2006.20.359

M. Stirratt, R. Remien, A. Smith, O. Copeland, C. Dolezal et al., The Role of HIV Serostatus Disclosure in Antiretroviral Medication Adherence, AIDS and Behavior, vol.90, issue.2, pp.483-493, 2006.
DOI : 10.1007/s10461-006-9106-6

P. Peretti-watel, B. Spire, J. Pierret, F. Lert, Y. Obadia et al., Management of HIV-related stigma and adherence to HAART: Evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003), AIDS Care, vol.328, issue.3, pp.254-261, 2006.
DOI : 10.1080/09540120500456193

URL : https://hal.archives-ouvertes.fr/inserm-00086761

M. Carrieri, F. Raffi, C. Lewden, A. Sobel, C. Michelet et al., Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study, Antivir Ther, vol.8, pp.585-594, 2003.

H. Liu, C. Golin, L. Miller, R. Hays, C. Beck et al., A Comparison Study of Multiple Measures of Adherence to HIV Protease Inhibitors, Annals of Internal Medicine, vol.134, issue.10, pp.968-977, 2001.
DOI : 10.7326/0003-4819-134-10-200105150-00011

P. Nieuwkerk and F. Oort, Self-Reported Adherence to Antiretroviral Therapy for HIV-1 Infection and Virologic Treatment Response, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.38, issue.4, pp.445-448, 2005.
DOI : 10.1097/01.qai.0000147522.34369.12

S. Duran, G. Peytavin, P. Carrieri, F. Raffi, J. Ecobichon et al., The detection of non-adherence by self-administered questionnaires can be optimized by protease inhibitor plasma concentration determination, AIDS, vol.17, issue.7, pp.1096-1099, 2003.
DOI : 10.1097/00002030-200305020-00025

S. Duran, C. Solas, B. Spire, M. Carrieri, J. Fuzibet et al., ???Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy???? A comparison between patients??? self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study, AIDS, vol.15, issue.8, pp.1075-1077, 2001.
DOI : 10.1097/00002030-200105250-00024